Are effector memory T cells the key to an effective HIV/AIDS vaccine?

Graphical Abstract Tried and true vaccine approaches to HIV have failed. Could Cytomegalovirus and its “goldilocks” level of viral persistence maintain robust, “effector memory” T‐cell responses and finally produce an effective, early‐intervention vaccine against HIV?

Saved in:
Bibliographic Details
Published in:EMBO reports 2014-08, Vol.15 (8), p.820-821
Main Author: Picker, Louis J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5512-19cab32ffe1801c13ef04b4fc133d0546b61a1a3678e5102469db7aa6b71a5763
cites cdi_FETCH-LOGICAL-c5512-19cab32ffe1801c13ef04b4fc133d0546b61a1a3678e5102469db7aa6b71a5763
container_end_page 821
container_issue 8
container_start_page 820
container_title EMBO reports
container_volume 15
creator Picker, Louis J
description Graphical Abstract Tried and true vaccine approaches to HIV have failed. Could Cytomegalovirus and its “goldilocks” level of viral persistence maintain robust, “effector memory” T‐cell responses and finally produce an effective, early‐intervention vaccine against HIV?
doi_str_mv 10.15252/embr.201439052
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4197036</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551027800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5512-19cab32ffe1801c13ef04b4fc133d0546b61a1a3678e5102469db7aa6b71a5763</originalsourceid><addsrcrecordid>eNqFkc1vEzEQxVcIREvhzA1Z4sJlG48_dzmAQhvaQCkSlMDN8jqz7bb70dqbQP57HDZEAQlx8kj-vTdv9JLkKdBDkEyyETaFP2QUBM-pZPeSfRAqTzno7P5mZgy-7SWPQrimlMpcZw-TPSbyjGZK7SeTsUeCZYmu7zxpsOn8ilwQh3UdSH-F5AZXpO-IbTdUtURyOp2NxtPjz2RpnatafP04eVDaOuCTzXuQfHk7uTg6Tc8-nkyPxmepkxJYCrmzBWfRBzIKDjiWVBSijBOfUylUocCC5UpnKIGyGH9eaGtVocFKrfhB8mrwvV0UDc4dtr23tbn1VWP9ynS2Mn_-tNWVueyWRkCuKV8bvNgY-O5ugaE3TRXWx9oWu0UwINd7dUZpRJ__hV53C9_G8wxoKTMtdCYiNRoo57sQPJbbMEDNr4rMuiKzrSgqnu3esOV_dxKBlwPwvapx9T8_M_nw5tOuOx3EIeraS_Q7qf8ZKB0kVejxx3af9TdGaa6l-Xp-Yt7N3mvG9cyc85_vOrq7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1755874784</pqid></control><display><type>article</type><title>Are effector memory T cells the key to an effective HIV/AIDS vaccine?</title><source>Open Access: PubMed Central</source><creator>Picker, Louis J</creator><creatorcontrib>Picker, Louis J</creatorcontrib><description>Graphical Abstract Tried and true vaccine approaches to HIV have failed. Could Cytomegalovirus and its “goldilocks” level of viral persistence maintain robust, “effector memory” T‐cell responses and finally produce an effective, early‐intervention vaccine against HIV?</description><identifier>ISSN: 1469-221X</identifier><identifier>EISSN: 1469-3178</identifier><identifier>DOI: 10.15252/embr.201439052</identifier><identifier>PMID: 24980866</identifier><identifier>CODEN: ERMEAX</identifier><language>eng</language><publisher>London: Blackwell Publishing Ltd</publisher><subject>AIDS Vaccines ; Animals ; EMBO19 ; EMBO52 ; HIV - immunology ; HIV Infections - prevention &amp; control ; Humans ; Immunologic Memory ; Opinion ; T-Lymphocyte Subsets</subject><ispartof>EMBO reports, 2014-08, Vol.15 (8), p.820-821</ispartof><rights>The Author 2014</rights><rights>2014 The Author</rights><rights>2014 EMBO</rights><rights>2014 The Author 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5512-19cab32ffe1801c13ef04b4fc133d0546b61a1a3678e5102469db7aa6b71a5763</citedby><cites>FETCH-LOGICAL-c5512-19cab32ffe1801c13ef04b4fc133d0546b61a1a3678e5102469db7aa6b71a5763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197036/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197036/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24980866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Picker, Louis J</creatorcontrib><title>Are effector memory T cells the key to an effective HIV/AIDS vaccine?</title><title>EMBO reports</title><addtitle>EMBO Rep</addtitle><addtitle>EMBO rep</addtitle><description>Graphical Abstract Tried and true vaccine approaches to HIV have failed. Could Cytomegalovirus and its “goldilocks” level of viral persistence maintain robust, “effector memory” T‐cell responses and finally produce an effective, early‐intervention vaccine against HIV?</description><subject>AIDS Vaccines</subject><subject>Animals</subject><subject>EMBO19</subject><subject>EMBO52</subject><subject>HIV - immunology</subject><subject>HIV Infections - prevention &amp; control</subject><subject>Humans</subject><subject>Immunologic Memory</subject><subject>Opinion</subject><subject>T-Lymphocyte Subsets</subject><issn>1469-221X</issn><issn>1469-3178</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkc1vEzEQxVcIREvhzA1Z4sJlG48_dzmAQhvaQCkSlMDN8jqz7bb70dqbQP57HDZEAQlx8kj-vTdv9JLkKdBDkEyyETaFP2QUBM-pZPeSfRAqTzno7P5mZgy-7SWPQrimlMpcZw-TPSbyjGZK7SeTsUeCZYmu7zxpsOn8ilwQh3UdSH-F5AZXpO-IbTdUtURyOp2NxtPjz2RpnatafP04eVDaOuCTzXuQfHk7uTg6Tc8-nkyPxmepkxJYCrmzBWfRBzIKDjiWVBSijBOfUylUocCC5UpnKIGyGH9eaGtVocFKrfhB8mrwvV0UDc4dtr23tbn1VWP9ynS2Mn_-tNWVueyWRkCuKV8bvNgY-O5ugaE3TRXWx9oWu0UwINd7dUZpRJ__hV53C9_G8wxoKTMtdCYiNRoo57sQPJbbMEDNr4rMuiKzrSgqnu3esOV_dxKBlwPwvapx9T8_M_nw5tOuOx3EIeraS_Q7qf8ZKB0kVejxx3af9TdGaa6l-Xp-Yt7N3mvG9cyc85_vOrq7</recordid><startdate>201408</startdate><enddate>201408</enddate><creator>Picker, Louis J</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><general>BlackWell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201408</creationdate><title>Are effector memory T cells the key to an effective HIV/AIDS vaccine?</title><author>Picker, Louis J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5512-19cab32ffe1801c13ef04b4fc133d0546b61a1a3678e5102469db7aa6b71a5763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>AIDS Vaccines</topic><topic>Animals</topic><topic>EMBO19</topic><topic>EMBO52</topic><topic>HIV - immunology</topic><topic>HIV Infections - prevention &amp; control</topic><topic>Humans</topic><topic>Immunologic Memory</topic><topic>Opinion</topic><topic>T-Lymphocyte Subsets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Picker, Louis J</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EMBO reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Picker, Louis J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are effector memory T cells the key to an effective HIV/AIDS vaccine?</atitle><jtitle>EMBO reports</jtitle><stitle>EMBO Rep</stitle><addtitle>EMBO rep</addtitle><date>2014-08</date><risdate>2014</risdate><volume>15</volume><issue>8</issue><spage>820</spage><epage>821</epage><pages>820-821</pages><issn>1469-221X</issn><eissn>1469-3178</eissn><coden>ERMEAX</coden><abstract>Graphical Abstract Tried and true vaccine approaches to HIV have failed. Could Cytomegalovirus and its “goldilocks” level of viral persistence maintain robust, “effector memory” T‐cell responses and finally produce an effective, early‐intervention vaccine against HIV?</abstract><cop>London</cop><pub>Blackwell Publishing Ltd</pub><pmid>24980866</pmid><doi>10.15252/embr.201439052</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1469-221X
ispartof EMBO reports, 2014-08, Vol.15 (8), p.820-821
issn 1469-221X
1469-3178
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4197036
source Open Access: PubMed Central
subjects AIDS Vaccines
Animals
EMBO19
EMBO52
HIV - immunology
HIV Infections - prevention & control
Humans
Immunologic Memory
Opinion
T-Lymphocyte Subsets
title Are effector memory T cells the key to an effective HIV/AIDS vaccine?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T20%3A44%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20effector%20memory%20T%20cells%20the%20key%20to%20an%20effective%20HIV/AIDS%20vaccine?&rft.jtitle=EMBO%20reports&rft.au=Picker,%20Louis%20J&rft.date=2014-08&rft.volume=15&rft.issue=8&rft.spage=820&rft.epage=821&rft.pages=820-821&rft.issn=1469-221X&rft.eissn=1469-3178&rft.coden=ERMEAX&rft_id=info:doi/10.15252/embr.201439052&rft_dat=%3Cproquest_pubme%3E1551027800%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5512-19cab32ffe1801c13ef04b4fc133d0546b61a1a3678e5102469db7aa6b71a5763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1755874784&rft_id=info:pmid/24980866&rfr_iscdi=true